AMGEN INC (1AMGN.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1AMGN - US0311621009 - Common Stock
278.45 EUR
-16.45 (-5.58%)
1AMGN gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 83 industry peers in the Biotechnology industry. While 1AMGN belongs to the best of the industry regarding profitability, there are concerns on its financial health. 1AMGN is not valued too expensively and it also shows a decent growth rate. Finally 1AMGN also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
In the past year 1AMGN was profitable.
1AMGN had a positive operating cash flow in the past year.
1AMGN had positive earnings in each of the past 5 years.
Each year in the past 5 years 1AMGN had a positive operating cash flow.
1.2 Ratios
1AMGN has a better Return On Assets (7.77%) than 80.72% of its industry peers.
1AMGN has a better Return On Equity (72.82%) than 100.00% of its industry peers.
With an excellent Return On Invested Capital value of 15.39%, 1AMGN belongs to the best of the industry, outperforming 91.57% of the companies in the same industry.
1AMGN had an Average Return On Invested Capital over the past 3 years of 13.04%. This is in line with the industry average of 12.74%.
The 3 year average ROIC (13.04%) for 1AMGN is below the current ROIC(15.39%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.77% | ||
| ROE | 72.82% | ||
| ROIC | 15.39% |
ROA(3y)7.14%
ROA(5y)8.52%
ROE(3y)118.78%
ROE(5y)104.3%
ROIC(3y)13.04%
ROIC(5y)14.18%
1.3 Margins
Looking at the Profit Margin, with a value of 19.47%, 1AMGN belongs to the top of the industry, outperforming 81.93% of the companies in the same industry.
In the last couple of years the Profit Margin of 1AMGN has declined.
1AMGN's Operating Margin of 33.57% is amongst the best of the industry. 1AMGN outperforms 89.16% of its industry peers.
In the last couple of years the Operating Margin of 1AMGN has declined.
1AMGN has a better Gross Margin (72.06%) than 62.65% of its industry peers.
In the last couple of years the Gross Margin of 1AMGN has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 33.57% | ||
| PM (TTM) | 19.47% | ||
| GM | 72.06% |
OM growth 3Y-6.36%
OM growth 5Y-7.03%
PM growth 3Y-18.6%
PM growth 5Y-18.28%
GM growth 3Y-2.94%
GM growth 5Y-3.32%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so 1AMGN is creating value.
The number of shares outstanding for 1AMGN has been increased compared to 1 year ago.
1AMGN has less shares outstanding than it did 5 years ago.
The debt/assets ratio for 1AMGN has been reduced compared to a year ago.
2.2 Solvency
The Debt to FCF ratio of 1AMGN is 4.28, which is a neutral value as it means it would take 1AMGN, 4.28 years of fcf income to pay off all of its debts.
1AMGN's Debt to FCF ratio of 4.28 is fine compared to the rest of the industry. 1AMGN outperforms 78.31% of its industry peers.
1AMGN has a Debt/Equity ratio of 5.45. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 5.45, 1AMGN is doing worse than 67.47% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.45 | ||
| Debt/FCF | 4.28 | ||
| Altman-Z | N/A |
ROIC/WACC1.81
WACC8.49%
2.3 Liquidity
1AMGN has a Current Ratio of 1.28. This is a normal value and indicates that 1AMGN is financially healthy and should not expect problems in meeting its short term obligations.
1AMGN has a Current ratio of 1.28. This is in the lower half of the industry: 1AMGN underperforms 67.47% of its industry peers.
1AMGN has a Quick Ratio of 1.28. This is a bad value and indicates that 1AMGN is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of 1AMGN (0.99) is worse than 68.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.28 | ||
| Quick Ratio | 0.99 |
3. Growth
3.1 Past
1AMGN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.79%, which is quite good.
Measured over the past 5 years, 1AMGN shows a small growth in Earnings Per Share. The EPS has been growing by 5.97% on average per year.
Looking at the last year, 1AMGN shows a quite strong growth in Revenue. The Revenue has grown by 10.56% in the last year.
Measured over the past years, 1AMGN shows a small growth in Revenue. The Revenue has been growing by 7.43% on average per year.
EPS 1Y (TTM)13.79%
EPS 3Y5.02%
EPS 5Y5.97%
EPS Q2Q%1.08%
Revenue 1Y (TTM)10.56%
Revenue growth 3Y8.76%
Revenue growth 5Y7.43%
Sales Q2Q%12.4%
3.2 Future
The Earnings Per Share is expected to grow by 4.48% on average over the next years.
The Revenue is expected to grow by 3.55% on average over the next years.
EPS Next Y9.43%
EPS Next 2Y6.17%
EPS Next 3Y5.25%
EPS Next 5Y4.48%
Revenue Next Year9.42%
Revenue Next 2Y5.5%
Revenue Next 3Y4.54%
Revenue Next 5Y3.55%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 14.91, the valuation of 1AMGN can be described as correct.
Based on the Price/Earnings ratio, 1AMGN is valued cheaply inside the industry as 86.75% of the companies are valued more expensively.
1AMGN's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.19.
1AMGN is valuated correctly with a Price/Forward Earnings ratio of 14.60.
1AMGN's Price/Forward Earnings ratio is rather cheap when compared to the industry. 1AMGN is cheaper than 93.98% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of 1AMGN to the average of the S&P500 Index (23.92), we can say 1AMGN is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.91 | ||
| Fwd PE | 14.6 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1AMGN indicates a rather cheap valuation: 1AMGN is cheaper than 80.72% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, 1AMGN is valued cheaper than 90.36% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.77 | ||
| EV/EBITDA | 12.5 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
1AMGN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.58
PEG (5Y)2.5
EPS Next 2Y6.17%
EPS Next 3Y5.25%
5. Dividend
5.1 Amount
1AMGN has a Yearly Dividend Yield of 3.11%. Purely for dividend investing, there may be better candidates out there.
1AMGN's Dividend Yield is rather good when compared to the industry average which is at 0.76. 1AMGN pays more dividend than 97.59% of the companies in the same industry.
1AMGN's Dividend Yield is rather good when compared to the S&P500 average which is at 1.92.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.11% |
5.2 History
On average, the dividend of 1AMGN grows each year by 9.41%, which is quite nice.
Dividend Growth(5Y)9.41%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
17.20% of the earnings are spent on dividend by 1AMGN. This is a low number and sustainable payout ratio.
The dividend of 1AMGN is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP17.2%
EPS Next 2Y6.17%
EPS Next 3Y5.25%
BIT:1AMGN (12/8/2025, 7:00:00 PM)
278.45
-16.45 (-5.58%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners83.83%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap149.94B
Revenue(TTM)35.97B
Net Income(TTM)7.00B
Analysts72.2
Price Target289.78 (4.07%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.11% |
Yearly Dividend7.7
Dividend Growth(5Y)9.41%
DP17.2%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.96%
Min EPS beat(2)10.28%
Max EPS beat(2)11.64%
EPS beat(4)4
Avg EPS beat(4)9.04%
Min EPS beat(4)2.49%
Max EPS beat(4)11.73%
EPS beat(8)7
Avg EPS beat(8)5.13%
EPS beat(12)10
Avg EPS beat(12)4.44%
EPS beat(16)14
Avg EPS beat(16)4.21%
Revenue beat(2)2
Avg Revenue beat(2)2.59%
Min Revenue beat(2)0.68%
Max Revenue beat(2)4.49%
Revenue beat(4)3
Avg Revenue beat(4)1.17%
Min Revenue beat(4)-0.84%
Max Revenue beat(4)4.49%
Revenue beat(8)3
Avg Revenue beat(8)-0.21%
Revenue beat(12)4
Avg Revenue beat(12)-0.48%
Revenue beat(16)5
Avg Revenue beat(16)-0.54%
PT rev (1m)5.64%
PT rev (3m)3.43%
EPS NQ rev (1m)0.07%
EPS NQ rev (3m)-11.17%
EPS NY rev (1m)1.12%
EPS NY rev (3m)2.12%
Revenue NQ rev (1m)-0.04%
Revenue NQ rev (3m)1.93%
Revenue NY rev (1m)1.86%
Revenue NY rev (3m)2.89%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.91 | ||
| Fwd PE | 14.6 | ||
| P/S | 4.88 | ||
| P/FCF | 13.77 | ||
| P/OCF | 13.38 | ||
| P/B | 18.26 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.5 |
EPS(TTM)18.67
EY6.7%
EPS(NY)19.08
Fwd EY6.85%
FCF(TTM)20.22
FCFY7.26%
OCF(TTM)20.81
OCFY7.47%
SpS57.04
BVpS15.25
TBVpS-51.05
PEG (NY)1.58
PEG (5Y)2.5
Graham Number80.04
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.77% | ||
| ROE | 72.82% | ||
| ROCE | 17.67% | ||
| ROIC | 15.39% | ||
| ROICexc | 17.86% | ||
| ROICexgc | 61.56% | ||
| OM | 33.57% | ||
| PM (TTM) | 19.47% | ||
| GM | 72.06% | ||
| FCFM | 35.46% |
ROA(3y)7.14%
ROA(5y)8.52%
ROE(3y)118.78%
ROE(5y)104.3%
ROIC(3y)13.04%
ROIC(5y)14.18%
ROICexc(3y)15.77%
ROICexc(5y)17.27%
ROICexgc(3y)75.76%
ROICexgc(5y)77.1%
ROCE(3y)14.97%
ROCE(5y)16.28%
ROICexgc growth 3Y3.26%
ROICexgc growth 5Y-18.2%
ROICexc growth 3Y-8.67%
ROICexc growth 5Y-7.85%
OM growth 3Y-6.36%
OM growth 5Y-7.03%
PM growth 3Y-18.6%
PM growth 5Y-18.28%
GM growth 3Y-2.94%
GM growth 5Y-3.32%
F-Score7
Asset Turnover0.4
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.45 | ||
| Debt/FCF | 4.28 | ||
| Debt/EBITDA | 2.97 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 74.3% | ||
| Profit Quality | 182.08% | ||
| Current Ratio | 1.28 | ||
| Quick Ratio | 0.99 | ||
| Altman-Z | N/A |
F-Score7
WACC8.49%
ROIC/WACC1.81
Cap/Depr(3y)24.77%
Cap/Depr(5y)23.42%
Cap/Sales(3y)3.59%
Cap/Sales(5y)3.31%
Profit Quality(3y)165.92%
Profit Quality(5y)155.23%
High Growth Momentum
Growth
EPS 1Y (TTM)13.79%
EPS 3Y5.02%
EPS 5Y5.97%
EPS Q2Q%1.08%
EPS Next Y9.43%
EPS Next 2Y6.17%
EPS Next 3Y5.25%
EPS Next 5Y4.48%
Revenue 1Y (TTM)10.56%
Revenue growth 3Y8.76%
Revenue growth 5Y7.43%
Sales Q2Q%12.4%
Revenue Next Year9.42%
Revenue Next 2Y5.5%
Revenue Next 3Y4.54%
Revenue Next 5Y3.55%
EBIT growth 1Y93.73%
EBIT growth 3Y1.84%
EBIT growth 5Y-0.13%
EBIT Next Year42.82%
EBIT Next 3Y11.34%
EBIT Next 5Y7.32%
FCF growth 1Y36%
FCF growth 3Y7.44%
FCF growth 5Y4.03%
OCF growth 1Y24.04%
OCF growth 3Y7.45%
OCF growth 5Y4.66%
AMGEN INC / 1AMGN.MI FAQ
What is the ChartMill fundamental rating of AMGEN INC (1AMGN.MI) stock?
ChartMill assigns a fundamental rating of 5 / 10 to 1AMGN.MI.
What is the valuation status of AMGEN INC (1AMGN.MI) stock?
ChartMill assigns a valuation rating of 6 / 10 to AMGEN INC (1AMGN.MI). This can be considered as Fairly Valued.
How profitable is AMGEN INC (1AMGN.MI) stock?
AMGEN INC (1AMGN.MI) has a profitability rating of 7 / 10.
What is the valuation of AMGEN INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for AMGEN INC (1AMGN.MI) is 14.91 and the Price/Book (PB) ratio is 18.26.
Is the dividend of AMGEN INC sustainable?
The dividend rating of AMGEN INC (1AMGN.MI) is 7 / 10 and the dividend payout ratio is 17.2%.